Views & Analysis Living with DMD: Inspiring each other’s futures Diagnosed with Duchenne muscular dystrophy (DMD) at three years old, Dr Jon Hastie grew up n
News Drug price controversies hit pharma's reputation Patient groups slam pharma over drug costs in latest survey.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.